Home » Topics » Regulatory

Regulatory
RSS

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

IND approved for new formulation of lidocaine

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Solvay and Elan to codevelop new formulation of fluvoxamine

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...